Patent details

301041 Product Name: Darolutamide, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout daarvan of in de vorm van een farmaceutisch aanvaardbare ester daarvan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301041
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2493858
Status:
SPC granted but not yet in force
Application number:
301041
Procedural language:
Dutch
First Applicant Residence Country:
Finland (FI)

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1432
Marketing Authorization Type:
EEA
Marketing Authorization Date:
30/03/2020
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
11/05/2020
First Marketing Authorization date:
30/03/2020
Grant date:
14/09/2020
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
12/05/2020
SPC/SPC Extension Expiration Date:
29/03/2035
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
11/05/2020
 
 

 

Name:
Orion Corporation
Address:
Orionintie 1, 02200 ESPOO, Finland (FI)

Agent

Name:
ir. F.A. Geurts c.s.
From:
11/05/2020
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
38/20
Publication date:
16/09/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
20/20
Publication date:
13/05/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/10/2030
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
14/09/2020 Publication Publication 1 PDF /5/7/2/3/5/0800553275/docs/301041_0_i2document20200914100521886.pdf
14/09/2020 Outgoing Correspondence Decision grant 1 PDF /5/7/2/3/5/0800553275/docs/301041_1_366150l504a.pdf
14/09/2020 Front Page Front Page 1 PDF /5/7/2/3/5/0800553275/docs/301041_9_i2frontpage20200914100521298.pdf
14/09/2020 SPC Documents Certificate SPC 1 PDF /5/7/2/3/5/0800553275/docs/301041_12_supplprotectioncertificate20200914121545025.pdf
02/09/2020 SPC Documents Accompanying letter SPC 2 PDF /5/7/2/3/5/0800553275/docs/301041_8_supplprotectioncertificate20200902043705782.pdf
06/07/2020 Outgoing Correspondence Letter to applicant 2 PDF /5/7/2/3/5/0800553275/docs/301041_5_352541l173.pdf
12/05/2020 Outgoing Correspondence Confirmation receipt request 1 PDF /5/7/2/3/5/0800553275/docs/301041_11_343620l174.pdf
11/05/2020 SPC Documents Marketing Authorization SPC 3 PDF /5/7/2/3/5/0800553275/docs/301041_2_supplprotectioncertificate20200512092125479.pdf
11/05/2020 SPC Documents Annex SPC 1 PDF /5/7/2/3/5/0800553275/docs/301041_3_supplprotectioncertificate20200512092125662.pdf
11/05/2020 SPC Documents Annex SPC 2 PDF /5/7/2/3/5/0800553275/docs/301041_4_supplprotectioncertificate20200512092125729.pdf
11/05/2020 Application Form First filed application form 4 PDF /5/7/2/3/5/0800553275/docs/301041_6_applicationform20200512092125360.pdf
11/05/2020 SPC Documents Annex SPC 2 PDF /5/7/2/3/5/0800553275/docs/301041_7_supplprotectioncertificate20200512092125803.pdf
11/05/2020 SPC Documents Summary of the characteristics of the product 16 PDF /5/7/2/3/5/0800553275/docs/301041_10_supplprotectioncertificate20200512092125553.pdf